This Ropes & Gray LLP memorandum discusses the Supreme Court's decision in Sorrell v. IMS Health Inc., which held that a Vermont statute that prohibits pharmaceutical manufacturers from obtaining or using "prescriber-identifiable information" collected from pharmacists for the purposes of "marketing or promoting a prescription drug - is a "speaker- and content-based burden on protected expression" that cannot survive "heightened judicial scrutiny."